Print this page

Balance Sheet of the Merck Group 

XLS

€ million

Sep. 30,
2011

December 31,
2010

Current assets

 

 

Cash and cash equivalents

1,137.2

943.7

Marketable securities and financial assets

983.0

55.6

Trade accounts receivable

2,351.9

2,296.3

Inventories

1,690.4

1,673.5

Other current assets

268.4

564.7

Tax receivables

98.3

93.7

Assets held for sale

36.7

 

6,529.2

5,664.2

Non-current assets

 

 

Intangible assets

11,753.0

12,484.1

Property, plant and equipment

3,061.1

3,241.5

Investments at equity

3.5

5.0

Non-current financial assets

82.6

130.3

Financial assets covering pensions

218.9

216.9

Other non-current assets

57.7

52.9

Deferred tax assets

688.0

593.1

 

15,864.9

16,723.8

 

 

 

Total assets

22,394.1

22,388.0

 

 

 

Current liabilities

 

 

Current financial liabilities

959.0

356.1

Trade accounts payable

1,124.2

1,200.1

Other current liabilities

1,017.8

1,054.6

Tax liabilities

401.8

368.4

Current provisions

333.0

374.5

Liabilities directly related to assets held for sale

5.9

 

3,835.8

3,359.6

Non-current liabilities

 

 

Non-current financial liabilities

4,604.2

5,127.4

Other non-current liabilities

35.0

42.9

Non-current provisions

547.9

524.2

Provisions for pensions and other
post-employment benefits

1,636.7

1,581.6

Deferred tax liabilities

1,297.9

1,380.5

 

8,121.7

8,656.6

Net equity

 

 

Equity capital

565.2

565.2

Reserves

8,646.1

8,484.2

Gains/losses recognized immediately in equity

1,180.2

1,280.4

Equity attributable to shareholder of the parent company

10,391.5

10,329.8

Non-controlling interest

45.1

42.0

 

10,436.6

10,371.8

 

 

 

Total liabilities and stockholders’ equity

22,394.1

22,388.0

© Merck KGaA, Darmstadt, Germany, Last Update 2011/10/26